Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both

- Pfeffer, Paul E., Ali, Nasloon, Altraja, Alan, Lehtimäki, Lauri, Papadopoulos, Nikolaos G., Salvi, Sundeep, Costello, Richard W., Cushen, Breda, Heffler, Enrico, Iwanaga, Takashi, Al-Ahmad, Mona, Larenas-Linnemann, Désirée, Murray, Ruth, Gibson, Peter G., Fonseca, JA, Al-Lehebi, R, Rhee, CK, Perez-de-Llano, L, Perng Steve, D-W, Mahboub, B, Wang, E, Goh, C, Lyu, J, Ulrik, Charlotte, Newell, A, Alacqua, M, Belevskiy, AS, Bhutani, M, Bjermer, L, Bjornsdottir, U, Bourdin, A, Bulow, AV, Busby, J, Canonica, GW, Tran, Trung N., Cosio, BG, Dorscheid, DR, Muñoz-Esquerre, M, FitzGerald, JM, Gil, EG, Gibson, PG, Heaney, LG, Hew, M, Hilberg, O, Hoyte, F, Maspero, Jorge, Jackson, DJ, Koh, MS, Ko, H-KB, Lee, JH, Lehmann, S, Chaves Loureiro, C, Lúðvíksdóttir, D, Menzies-Gow, AN, Mitchell, P, Papaioannou, AI, Peters, Matthew, Popov, TA, Porsbjerg, CM, Salameh, L, Sirena, C, Taillé, C, Taube, C, Tohda, Y, Wechsler, ME, Price, DB, Christoff, George C., Sadatsafavi, Mohsen, Torres-Duque, Carlos A.

Development of the international severe asthma registry (ISAR): a modified Delphi study

- Bulathsinhala, Lakmini, Eleangovan, Nevaashni, Belhassen, Manon, Harvey, Erin S., Perez de Llano, Luis, Maitland-van der Zee, Anke H., Papadopoulos, Nikolaos G., FitzGerald, J. Mark, Porsbjerg, Celeste, Canonica, G. Walter, Backer, Vibeke, Rhee, Chin Kook, Heaney, Liam G., Verhamme, Katia M. C., Buhl, R, Cosio, BG, Carter, V, Price, C, Le, T, Stagno d'Alcontres, M, Gopalan, G, Tran, TN, Price, D, Menzies-Gow, Andrew, Gibson, Peter G., Peters, Matthew, Hew, Mark, van Boven, Job F. M., Lehtimäki, Lauri, van Ganse, Eric